These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1719142)

  • 1. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Hatch KD; Homesley HD
    J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
    Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
    Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide].
    Huang H; Lian L; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):265-9. PubMed ID: 7544256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
    Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
    Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant chemotherapy in dysgerminoma].
    Fechtig A; de Dycker RP; Schumacher T; Neumann RL
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of dysgerminoma].
    Brökelmann J; Hartlapp JH
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):282-4. PubMed ID: 3596209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced stage of dysgerminoma in testicular feminisation: is radical surgery necessary?
    Chan LY; Wong SF; Yu VS
    Aust N Z J Obstet Gynaecol; 2000 May; 40(2):224-5. PubMed ID: 10925918
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes.
    Takemori M; Ichimura T; Nishimura R; Hasegawa K
    Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of advanced testicular cancer.
    Williams SD; Loehrer PJ; Einhorn LH
    Semin Urol; 1984 Nov; 2(4):230-7. PubMed ID: 6209762
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian germ cell malignancies: the Yale University experience.
    Schwartz PE; Chambers SK; Chambers JT; Kohorn E; McIntosh S
    Gynecol Oncol; 1992 Apr; 45(1):26-31. PubMed ID: 1376294
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
    Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
    J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
    Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
    Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
    Smith EB; Clarke-Pearson DL; Creasman WT
    Am J Obstet Gynecol; 1984 Dec; 150(8):927-31. PubMed ID: 6542313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of germ cell tumors of the ovary].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
    Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
    Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).
    Slayton RE; Park RC; Silverberg SG; Shingleton H; Creasman WT; Blessing JA
    Cancer; 1985 Jul; 56(2):243-8. PubMed ID: 2988740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ovarian endodermal sinus tumor.
    Lian L; Huang H; Huang R; Lang J
    Chin Med J (Engl); 1996 May; 109(5):344-8. PubMed ID: 9208488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.